↓ Skip to main content

Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study

Overview of attention for article published in BMC Cancer, March 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
9 X users

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study
Published in
BMC Cancer, March 2014
DOI 10.1186/1471-2407-14-219
Pubmed ID
Authors

Sasja F Mulder, Dirk Bertens, Ingrid ME Desar, Kris CP Vissers, Peter FA Mulders, Cornelis JA Punt, Dick-Johan van Spronsen, Johan F Langenhuijsen, Roy PC Kessels, Carla ML van Herpen

Abstract

Impairment of cognitive functioning has been reported in several studies in patients treated with chemotherapy. So far, no studies have been published on the effects of the vascular endothelial growth factor receptor (VEGFR) inhibitors on cognitive functioning. We investigated the objective and subjective cognitive function of patients during treatment with VEGFR tyrosine kinase inhibitors (VEGFR TKI).

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Unknown 109 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 16 15%
Researcher 14 13%
Student > Bachelor 13 12%
Student > Master 10 9%
Professor 8 7%
Other 24 22%
Unknown 25 23%
Readers by discipline Count As %
Medicine and Dentistry 25 23%
Psychology 15 14%
Nursing and Health Professions 11 10%
Biochemistry, Genetics and Molecular Biology 6 5%
Neuroscience 6 5%
Other 16 15%
Unknown 31 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2014.
All research outputs
#6,185,237
of 24,571,708 outputs
Outputs from BMC Cancer
#1,519
of 8,717 outputs
Outputs of similar age
#54,176
of 228,827 outputs
Outputs of similar age from BMC Cancer
#30
of 133 outputs
Altmetric has tracked 24,571,708 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 8,717 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,827 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 133 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.